Tekmira Seeks DQ Of McDermott For Past Patent Work

Law360, New York (May 30, 2012, 2:52 PM EDT) -- Tekmira Pharmaceuticals Corp. on Tuesday sought the disqualification of Alnylam Pharmaceuticals Inc. counsel McDermott Will & Emery LLP, saying that a McDermott attorney's past work for Tekmira represents a conflict of interest with Alnylam's molecule patent infringement case against the genetics company.

Tekmira told the Massachusetts federal court that McDermott attorney Barrington Dyer's past work for the genetics therapy laboratory in a similar patent infringement dispute mandated that he and his employer be excluded from representing the plaintiffs in a case brought by Alnylam and Isis...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.